Scholarlink

<p>Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease associated with inflammation implicated in the development of vasculitis, specifically microscopic polyangiitis (MPA). Herein, we report a case of MPA complicated by IPF. A woman in her 70s with a history of IPF treated with nintedanib presented with a serum creatinine level of 2.22&#xa0;mg/dL, microscopic hematuria, and a serum myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) titer level of 78.5&#xa0;IU/mL. The initial renal biopsy revealed diffuse tubulointerstitial nephritis without glomerular crescent formation; therefore, prednisolone was initiated. However, the serum MPO-ANCA titer level increased to 91.1&#xa0;IU/mL after tapering the prednisolone dose. A second renal biopsy revealed pauci-immune necrotizing glomerulonephritis with crescents, confirming MPA. Treatment was adjusted to include a resumed steroid regimen and combination therapy with rituximab and avacopan, resulting in stable kidney function. In conclusion, this case underscores the importance of monitoring serum ANCA titer levels as a surrogate marker for subclinical vasculitis in patients with IPF. The sequential occurrence of tubulointerstitial nephritis followed by crescentic glomerulonephritis suggests a potential progression pattern in MPA, warranting careful clinical and histopathological evaluations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microscopic polyangiitis with histopathologic evolution in serial renal biopsies during treatment of idiopathic pulmonary fibrosis

  • 期刊论文

  • 发表日期：

    2025年8月13日

查看全文
  • Yuya Yamaguchi,
  • Takeshi Tosaki,
  • Takaya Sasaki,
  • Daisuke Nakashima,
  • Yu Honda,
  • Shinya Yokote,
  • Nobuo Tsuboi,
  • Takashi Yokoo

摘要

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease associated with inflammation implicated in the development of vasculitis, specifically microscopic polyangiitis (MPA). Herein, we report a case of MPA complicated by IPF. A woman in her 70s with a history of IPF treated with nintedanib presented with a serum creatinine level of 2.22 mg/dL, microscopic hematuria, and a serum myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) titer level of 78.5 IU/mL. The initial renal biopsy revealed diffuse tubulointerstitial nephritis without glomerular crescent formation; therefore, prednisolone was initiated. However, the serum MPO-ANCA titer level increased to 91.1 IU/mL after tapering the prednisolone dose. A second renal biopsy revealed pauci-immune necrotizing glomerulonephritis with crescents, confirming MPA. Treatment was adjusted to include a resumed steroid regimen and combination therapy with rituximab and avacopan, resulting in stable kidney function. In conclusion, this case underscores the importance of monitoring serum ANCA titer levels as a surrogate marker for subclinical vasculitis in patients with IPF. The sequential occurrence of tubulointerstitial nephritis followed by crescentic glomerulonephritis suggests a potential progression pattern in MPA, warranting careful clinical and histopathological evaluations.